All companies › CAMP

CAMP · Camp4 Therapeutics Corp

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys1
Open-market sells6
Total purchased$39,600
Unique insiders buying1
Most senior buyerCFO
Avg price paid$3.96
Research cases0
Last filing2026-08-31

Average price paid is weighted by shares, so a large purchase counts for more than a small one. It is what insiders reported paying, not a target or a fair value.

Insider flow: Net selling by value — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-08-19 — Schwab Andrew J. · sold 45,147 @ $4.76 2026-08-19 — Tardiff Daniel · sold 1,738 @ $4.76 2026-08-20 — Schwab Andrew J. · sold 114,700 @ $4.54 2026-08-21 — Schwab Andrew J. · sold 32,018 @ $4.50 2026-08-24 — Schwab Andrew J. · sold 10 @ $4.50 2026-08-27 — Schwab Andrew J. · sold 400,000 @ $4.04 2026-08-31 — Gold Kelly · bought 10,000 @ $3.96
2026-08-192026-08-31

Insider cost basis

Share-weighted average price across 1 reported purchase, with the full range of prices paid. Purchases only — averaging a sale into an "insider cost" would describe a price nobody paid.

$3.96 $3.96
$3.96 weighted average insider purchase price

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Schwab Andrew J. Director
Tardiff Daniel Chief Scientific Officer
Gold Kelly Chief Financial Officer
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $CAMP is the reading of them — and for this company, that is what the list below says it is, no more.

  • Insider cost basisShare-weighted average price paid across the 1 reported purchase, with the full range, against the current price.
  • Insider participationWho bought, how often, and how the buying is distributed across the people filing — one person repeating is not several agreeing.
  • Transaction timelineThe [{'transaction_date': '2026-08-31', 'insider_name': 'Gold Kelly', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market buy', 'shares': 10000.0, 'price': 3.96, 'value': 39600.0, 'is_buy': True}, {'transaction_date': '2026-08-27', 'insider_name': 'Schwab Andrew J.', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 400000.0, 'price': 4.04, 'value': 1616000.0, 'is_buy': False}, {'transaction_date': '2026-08-24', 'insider_name': 'Schwab Andrew J.', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 10.0, 'price': 4.5, 'value': 45.0, 'is_buy': False}, {'transaction_date': '2026-08-21', 'insider_name': 'Schwab Andrew J.', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 32018.0, 'price': 4.5, 'value': 144081.0, 'is_buy': False}, {'transaction_date': '2026-08-20', 'insider_name': 'Schwab Andrew J.', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 114700.0, 'price': 4.54, 'value': 520738.0, 'is_buy': False}, {'transaction_date': '2026-08-19', 'insider_name': 'Schwab Andrew J.', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 45147.0, 'price': 4.76, 'value': 214899.72, 'is_buy': False}, {'transaction_date': '2026-08-19', 'insider_name': 'Tardiff Daniel', 'insider_title': 'Chief Scientific Officer', 'transaction_type': 'Open-market sell', 'shares': 1738.0, 'price': 4.76, 'value': 8272.88, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for CAMP today: no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.